featured-Reporter
-
February 23, 2017
Team identifies ‘switch’ involved in DNA replication
DNA replication is an extraordinarily complex multi-step process that makes copies of the body’s genetic blueprint. It is necessary for growth and essential to life. Now researchers at the California Institute of Technology (Caltech) and Vanderbilt University have found evidence that one of those steps may involve the telephone-like transmission of electrical signals regulated by a chemical “switch.” -
February 23, 2017
Researchers chart new informatics path in tracking disease risk
In a study in Circulation: Cardiovascular Genetics, Vanderbilt University’s Jonathan Mosley, M.D., Ph.D., and colleagues use genetic correlation to hitch together two unrelated sets of data, one from a longstanding epidemiological cohort and the other from electronic health records. -
February 16, 2017
Volunteer finds common ground with trauma patients
By 5 each morning, businessman Doug Brown is already hard at work, making calls to colleagues around the world. -
February 16, 2017
Grant strengthens Brantley’s vision research efforts
Milam Brantley Jr., M.D., Ph.D., associate professor of Ophthalmology and Visual Sciences and Molecular Physiology and Biophysics, recently received a $500,000 grant from the Edward N. and Della L. Thome Memorial Foundation Awards Program in Macular Degeneration Research to further his work on age-related macular degeneration (AMD). -
February 16, 2017
Barut named CNO of Psychiatric Hospital, VBH
Jennifer Barut, MSN, R.N., has been named chief nursing officer for Vanderbilt Psychiatric Hospital (VPH) and Vanderbilt Behavioral Health (VBH). -
February 9, 2017
VUMC testing device to reduce stroke risk in arrhythmia patients
Vanderbilt University Medical Center (VUMC) is the first in the state to enroll patients in a clinical trial testing the effectiveness of the newest implantable device used to reduce stroke risk in patients with non-valvular atrial fibrillation (AF), the most common form of arrhythmia. -
February 9, 2017
Team isolates new antibodies that may aid RSV vaccine design
Researchers at Vanderbilt University Medical Center (VUMC) have taken another step toward developing a vaccine against respiratory syncytial virus (RSV), the major cause of life-threatening pneumonia in infants worldwide.